CNRS Press l Véronique Etienne l T +33 (0)1 44 96 51 37 l firstname.lastname@example.org
A veritable sensor: a team of Inserm and CNRS researchers at the Institute of Pharmacology and Structural Biology (IPBS, CNRS/Paul Sabatier University – Toulouse III) has identified a protein that is able to detect various allergens in the respiratory tract, which are responsible for asthma attacks. This study, co-led by Corinne Cayrol and Jean-Philippe Girard, was published in Nature Immunology on March 19, 2018. It offers hope for breakthroughs in the treatment of allergic illnesses.
What do mold, pollen and cockroaches have in common? Although they belong to three distinct kingdoms of the living world, they can all trigger asthma attacks in people sensitive to them. And all of them, despite their very different compositions, contain enzymes called proteases.
The IPBS team has identified a human protein that reacts to a large number of environmental allergens: interleukin-33 (IL-33). When they enter the human respiratory tract, the allergens release their proteases. These split the IL-33 into extremely reactive fragments which trigger the chain reactions behind allergy symptoms.
This appears to be a general mechanism responsible for triggering allergic reactions. Indeed, IL-33 was shown to detect each of the 14 allergens tested, some of which are present in ambient air (several types of pollen, house dust mites, fungal spores) and others implicated in occupational asthma (such as subtilisin, found in detergents).
Furthermore, clinical trials now under way are focusing on this protein. And they are on the right track, given this recent discovery of a single mechanism for detection of airborne allergens by IL-33. Inhibiting the production of reactive IL-33 fragments following allergen exposure could, for example, limit severe allergic reactions in asthmatic patients.
Mucous production in the lung following inhalation of an allergen : IL-33 sensor present (left), IL-33 sensor deactivated (right) (lung sections, mucous shown in magenta).
Excessive mucous production is characteristic of allergic asthma. Protein IL-33, a major factor predisposing humans to asthma, detects allergen protease activity. Activated by proteases, IL-33 sets off a cascade of reactions, including mucus production, that are associated with asthma and other allergic illnesses. When IL-33 activation is inhibited (on the right), these reactions are not triggered.
© Corinne Cayrol and Jean-Philippe Girard / IPBS / CNRS-Paul Sabatier University – Toulouse III
Hypoallergenic formulas are recommended for infants who are not exclusively breastfed and who are at risk of developing allergies. While it is assumed that such formulas reduce the development of allergies later in life, it is unclear whether this claim is true. ...
How is HIV able to escape the surveillance of the immune system within the very cells it infects? Researchers from Inserm, CNRS, Université de Montpellier and Université de Lorraine decided to take a closer look at one of these evasion mechanisms. They ...
Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Corinne Cayrol*, Anais Duval*, Pauline Schmitt, Stephane Roga, Mylène Camus, Alexandre Stella, Odile Burlet-Schiltz, Anne Gonzalez-de-Peredo and Jean-Philippe Girard. Nature Immunology, March 19, 2018. DOI: http://dx.doi.org/10.1038/s41590-018-0067-5